No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BEN240816P22500
- 0.33
- +0.04+13.79%
15min DelayClose Jul 23 15:54 ET
0.35High0.27Low
0.30Open0.29Pre Close54 Volume528 Open Interest22.50Strike Price1.68KTurnover28.47%IV4.48%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type-0.3081Delta0.2072Gamma66.31Leverage Ratio-0.0115Theta-0.0044Rho-20.43Eff Leverage0.0211Vega
Intraday
- 5D
- Daily
News
Express News | Franklin Templeton Launches Franklin Ethereum ETF (Ezet)
Express News | Franklin Templeton Selects Aladdin by BlackRock to Unify Its Investment Management Technology
Will Lower Market Volatility Hurt Franklin's (BEN) Q3 Earnings?
Morgan Stanley Adjusts Franklin Resources' Price Target to $22 From $24, Maintains Underweight Rating
Morgan Stanley Maintains Franklin Resources(BEN.US) With Sell Rating, Cuts Target Price to $22
J.P. Morgan Keeps Their Hold Rating on Franklin Resources (BEN)
Comments
Morning mooers! It is Monday, April 29th, and the market is open and chugging away on most recent earnings. This week is the most jam packed earnings week so far, with 175 firms in the S&P 500 reporting.
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
My name is Kevin Travers, and I am writing this update from the Nasdaq offices in Times Square, where moomooo is holding a partnership event! Tune in to the live tab to see the presentations and KOL features.
Here are your morning moovers:...
14
$Amylyx Pharmaceuticals(AMLX.US$
I have no doubt in Franklin, especially when both are together in one stock![]()
. I think both $Franklin Resources(BEN.US$ and $Franklin Biotechnology Discovery Fund(LU0109394709.MF$ are here. I don't know the second one could not link to AMLX.US, is it his holding company?
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
I have no doubt in Franklin, especially when both are together in one stock
Relyvrio is approved in the US, Albrioza in Canada. AKA Phoenix.
Pegasus (Phase 2) is in there for Alzheimer. Helios (Phase 2) for Wolfram Syndrome and Orion (P...
2
Insider selling, especially the large scale by Alok Sethi and lack of buying in past year, creates concern despite high level of insider ownership. The sale above the current share price does not reveal insider sentiment about company value.
Franklin Templeton eyes significant growth in Canada, expecting Andrew Ashton's expertise to fuel expansion. The potential acquisition of Putnam Investments may unlock new opportunities.
Market overreactions and irrational behavior of investors may lead to discrepancies between a company's fundamentals and its stock performance. The drop in Franklin Resources' stock may be due to past unreasonable growth expectations or a potential one-off gain or loss that is ignored.
Read more